Your browser doesn't support javascript.
loading
Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment in a real-world clinical setting (AHEAD-G202).
Wang, Xiang; Zhong, Diansheng; Zhang, Junping; Du, Nan; Ren, Yuchuan; Gao, Jinghua; Liu, Likun; Yu, Junyan; Li, Xiaomei; Ma, Liwen; Zang, Aimin; Yang, Mudan; Zhang, Yan; Guo, Jun; Liu, Zheng; Fu, Zhanzhao; Jia, Junmei; Diao, Jianfeng; Fan, Zaiwen; Song, Xiang; Li, Guozhong; Wang, Huaqing; Bai, Chunmei; Guan, Mei; Ren, Xiubao; Zhang, Ruixing.
Afiliação
  • Wang X; Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Zhong D; Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, China.
  • Zhang J; Department of Medical Oncology, Shanxi Academy of Medical Sciences, Shanxi Dayi Hospital, Taiyuan, China.
  • Du N; Department of Medical Oncology, Fourth Medical Center of PLA General Hospital, Beijing, China.
  • Ren Y; Department of Oncology, Yangquan First People's Hospital, Yangquan, China.
  • Gao J; Department of Medical Oncology, Cangzhou Central Hospital, Cangzhou, China.
  • Liu L; Oncology Department, Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, China.
  • Yu J; Department of Oncology, Peace Hospital of Changzhi Medical College, Changzhi, China.
  • Li X; Department of Medical Oncology, Chinese PLA General Hospital, Medical School of Chinese PLA, Beijing, China.
  • Ma L; Department of Tumor Chemotherapy and Radiology, Peking University Third Hospital, Beijing, China.
  • Zang A; Department of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, China.
  • Yang M; Digestive Department of Oncology, Shanxi Tumor Hospital, Taiyuan, China.
  • Zhang Y; Department of Medical Oncology, Shijiazhuang People's Hospital, Shijiazhuang, China.
  • Guo J; Department of Medical Oncology, Xingtai People's Hospital, Hebei Medical University Affiliated Hospital, Xingtai, China.
  • Liu Z; Department of Radiology, Handan Central Hospital, Handan, China.
  • Fu Z; Department of Medical Oncology, First Hospital of Qinhuangdao, Qinhuangdao, China.
  • Jia J; Department of Medical Oncology, First Hospital of Shanxi Medical University, Taiyuan, China.
  • Diao J; Department of Medical Oncology, Datong Second People's Hospital, Datong, China.
  • Fan Z; Department of Medical Oncology, Air Force General Hospital, PLA, Beijing, China.
  • Song X; Department of Medical Oncology, Second Hospital of Shanxi Medical University, Taiyuan, China.
  • Li G; Department of Medical Oncology, Peking University Binhai Hospital, Tianjin, China.
  • Wang H; Department of Medical Oncology, Tianjin People's Hospital, Tianjin, China.
  • Bai C; Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Guan M; Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Ren X; Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Zhang R; Department of Gastroenterology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
J Gastrointest Oncol ; 13(4): 1679-1689, 2022 Aug.
Article em En | MEDLINE | ID: mdl-36092345
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article